AI assistant
ORASURE TECHNOLOGIES INC — Director's Dealing 2017
Jun 30, 2017
33573_dirs_2017-06-29_b06754ae-f3a0-4684-bf62-de4009882199.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORASURE TECHNOLOGIES INC (OSUR)
CIK: 0001116463
Period of Report: 2017-06-27
Reporting Person: Michels Douglas A (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-27 | Common stock | M | 125954 | $11.295 | Acquired | 894012 | Direct |
| 2017-06-27 | Common stock | M | 75000 | $11.295 | Acquired | 969012 | Direct |
| 2017-06-27 | Common stock | M | 89541 | $9.305 | Acquired | 1058553 | Direct |
| 2017-06-27 | Common stock | S | 125954 | $17.133 | Disposed | 932599 | Direct |
| 2017-06-27 | Common stock | S | 75000 | $16.673 | Disposed | 857599 | Direct |
| 2017-06-27 | Common stock | S | 89541 | $16.281 | Disposed | 768058 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-27 | Nonqualified stock options | $11.295 | M | 125954 | Disposed | 2022-02-01 | Common stock (125954) | Direct |
| 2017-06-27 | Nonqualified stock options | $11.295 | M | 75000 | Disposed | 2022-02-01 | Common stock (75000) | Direct |
| 2017-06-27 | Nonqualified stock options | $9.305 | M | 89541 | Disposed | 2025-02-03 | Common stock (89541) | Direct |
Footnotes
F1: Sale pursuant to a predetermined sales plan, entered into on May 24, 2017, under Rule 10b5-1 of the Securities and Exchange Act of 1934.
F2: Nonqualified stock options granted on February 1, 2012 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
F3: Nonqualified stock options granted on February 3, 2015 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.